mybacs is a research-driven DTC company specialized in the human microbiome.
mybacs has raised $5.9M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
mybacs's investors include naturalX Health Ventures, Global Founders Capital, Joyance Partners, WENVEST Capital, Social Starts.
mybacs is headquartered in Zug, Switzerland.
mybacs is a research-driven DTC company specialized in the human microbiome.
mybacs is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"mybacs — Funding & Investors." VCBacked, October 19, 2023, https://www.vcbacked.co/company/mybacs. Accessed July 20, 2026.
VCBacked. (2023). mybacs — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/mybacs
{{cite web |title=mybacs — Funding & Investors |url=https://www.vcbacked.co/company/mybacs |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated